The introduction of nicotinamide being a nicotine alternative in e-cigarette and smokeless merchandise represents an important regulatory problem for your FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is understood to act as a sedative at significant dosages6. The promises produced by Nicotine River, ECBlend, and also other